Cameron J. Herting

1.8k total citations · 1 hit paper
18 papers, 862 citations indexed

About

Cameron J. Herting is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Cameron J. Herting has authored 18 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Cameron J. Herting's work include Glioma Diagnosis and Treatment (9 papers), Immune cells in cancer (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Cameron J. Herting is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Immune cells in cancer (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Cameron J. Herting collaborates with scholars based in United States, Spain and United Kingdom. Cameron J. Herting's co-authors include Dolores Hambardzumyan, Zhihong Chen, Rikke Rasmussen, Susanne A. Wolf, Bhakti Dwivedi, Xi Feng, David H. Gutmann, Kai Nie, Sandra Seby and Winnie W. Pong and has published in prestigious journals such as Science, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Cameron J. Herting

15 papers receiving 859 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma

2017 488 citations Zhihong Chen, Xi Feng et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cameron J. Herting United States	11	500	362	291	244	207	18	862
Anna Gieryng Poland	9	402 0.8×	282 0.8×	230 0.8×	162 0.7×	282 1.4×	12	796
Kati Turkowski Germany	13	530 1.1×	211 0.6×	303 1.0×	205 0.8×	301 1.5×	17	922
Klara Soukup Austria	10	437 0.9×	316 0.9×	299 1.0×	299 1.2×	151 0.7×	18	894
Katyayni Vinnakota Germany	8	448 0.9×	324 0.9×	306 1.1×	204 0.8×	312 1.5×	9	885
Kacper A. Walentynowicz Poland	4	449 0.9×	331 0.9×	252 0.9×	146 0.6×	230 1.1×	5	722
Katarzyna C. Pituch United States	13	597 1.2×	316 0.9×	328 1.1×	414 1.7×	133 0.6×	16	1.1k
Susan Brandenburg Germany	16	699 1.4×	304 0.8×	233 0.8×	201 0.8×	434 2.1×	23	1.1k
Susobhan Sarkar Canada	19	564 1.1×	429 1.2×	409 1.4×	381 1.6×	264 1.3×	29	1.3k
Anantha Marisetty United States	11	295 0.6×	236 0.7×	323 1.1×	168 0.7×	115 0.6×	18	720
Garima Yagnik United States	15	540 1.1×	423 1.2×	579 2.0×	352 1.4×	176 0.9×	25	1.3k

Countries citing papers authored by Cameron J. Herting

Since Specialization

Citations

This map shows the geographic impact of Cameron J. Herting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron J. Herting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron J. Herting more than expected).

Fields of papers citing papers by Cameron J. Herting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron J. Herting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron J. Herting. The network helps show where Cameron J. Herting may publish in the future.

Co-authorship network of co-authors of Cameron J. Herting

This figure shows the co-authorship network connecting the top 25 collaborators of Cameron J. Herting. A scholar is included among the top collaborators of Cameron J. Herting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cameron J. Herting. Cameron J. Herting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Alese, Olatunji B., Natalie K. Horvat, Emily R. Greene, et al.. (2025). XL888 and pembrolizumab modulate the immune landscape of colorectal tumors in a phase Ib/II clinical trial. OncoImmunology. 14(1). 2475620–2475620. 5 indexed citations

Greene, Emily R., Natalie K. Horvat, Deon B. Doxie, et al.. (2025). High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma. Cancer Research.

Saddala, Madhu Sudhana, Jeremy B. Foote, Ateeq Khaliq, et al.. (2024). Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine. Cell Reports Medicine. 6(1). 101881–101881. 4 indexed citations

Horvat, Natalie K., Megan M. Wyatt, Margaret A. Hall, et al.. (2024). Clinically relevant orthotopic pancreatic cancer models for adoptive T cell transfer therapy. Journal for ImmunoTherapy of Cancer. 12(1). e008086–e008086. 6 indexed citations

Shi, Xiaojun, Cameron J. Herting, Yifan Ge, et al.. (2023). Time-resolved live-cell spectroscopy reveals EphA2 multimeric assembly. Science. 382(6674). 1042–1050. 22 indexed citations

Kasi, Pashtoon Murtaza, et al.. (2023). Anti-EGFR Antibodies in the Management of Advanced Colorectal Cancer. The Oncologist. 28(12). 1034–1048. 20 indexed citations

Dwivedi, Bhakti, et al.. (2022). High-risk gene expression in colorectal liver metastasis: Potential for novel therapies.. Journal of Clinical Oncology. 40(4_suppl). 147–147.

Akce, Mehmet, Walid L. Shaib, Maria Diab, et al.. (2022). Phase Ib/II trial of siltuximab and spartalizumab in patients in metastatic pancreatic cancer.. Journal of Clinical Oncology. 40(4_suppl). TPS626–TPS626. 7 indexed citations

Herting, Cameron J., et al.. (2021). The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions. Cancer and Metastasis Reviews. 40(3). 675–689. 42 indexed citations

10.

Herting, Cameron J., Matthew R. Farren, Yan Tong, et al.. (2021). A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer: HCRN GI14-186. Cancer Immunology Immunotherapy. 70(11). 3337–3348. 23 indexed citations

11.

Chen, Zhihong, Cameron J. Herting, James Ross, et al.. (2020). Genetic driver mutations introduced in identical cell‐of‐origin in murine glioblastoma reveal distinct immune landscapes but similar response to checkpoint blockade. Glia. 68(10). 2148–2166. 31 indexed citations

12.

Ross, James, Zhihong Chen, Cameron J. Herting, et al.. (2020). Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma. Brain. 144(1). 53–69. 47 indexed citations

13.

Maximov, Victor, Zhihong Chen, Yun Wei, et al.. (2019). Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nature Communications. 10(1). 2410–2410. 75 indexed citations

14.

Boyd, Nathaniel, Kiera Walker, Emily R. Gordon, et al.. (2019). Chromodomain Helicase DNA-Binding Protein 7 Is Suppressed in the Perinecrotic/Ischemic Microenvironment and Is a Novel Regulator of Glioblastoma Angiogenesis. Stem Cells. 37(4). 453–462. 18 indexed citations

15.

Herting, Cameron J., Zhihong Chen, Victor Maximov, et al.. (2019). Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema. Brain. 142(12). 3834–3851. 49 indexed citations

16.

Núñez, Felipe J., Flor Mendez, Padma Kadiyala, et al.. (2018). GENE-35. IDH1-R132H INDUCES AN EPIGENETIC REPROGRAMMING IN GLIOMA IMPACTING MEDIAN SURVIVAL, DNA-DAMAGE RESPONSE AND RADIO-SENSITIVITY. Neuro-Oncology. 20(suppl_6). vi111–vi111.

17.

Carlin, Cathleen R., Manmeet S. Ahluwalia, Adam Lauko, et al.. (2017). Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival. Clinical Cancer Research. 23(22). 7059–7071. 25 indexed citations

18.

Chen, Zhihong, Xi Feng, Cameron J. Herting, et al.. (2017). Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma. Cancer Research. 77(9). 2266–2278. 488 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact